Skip to main
WALD

WALD Stock Forecast & Price Target

WALD Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 67%
Buy 0%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Waldencast is facing challenges due to underperforming results, and management's decision not to provide guidance for FY26. The company's recent financials have been adversely affected by slower than expected growth and elevated margin pressure. However, the company is taking measures to improve its performance, including conducting a strategic review to maximize shareholder value. The success of Obagi's entry into the filler market and its momentum in eCommerce channels provides potential for growth, but execution risk remains. Milk's recent struggles and international demand issues have caused management to reorganize the brand.

Bears say

Waldencast is facing several challenges that could hinder its future growth and profitability. The company's reliance on third-party suppliers and potential dilution from securities offerings could lead to disruptions in its business and negatively impact its stock price. Furthermore, the company's heavy dependence on one distributor for its Obagi products in the highly competitive beauty market could limit its growth potential. The ongoing SEC investigation and potential for slowed growth in the beauty market could also add pressure to the company's financials.

WALD has been analyzed by 3 analysts, with a consensus rating of Buy. 67% of analysts recommend a Strong Buy, 0% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Waldencast Acquisition Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Waldencast Acquisition Corp (WALD) Forecast

Analysts have given WALD a Buy based on their latest research and market trends.

According to 3 analysts, WALD has a Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $2.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $2.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Waldencast Acquisition Corp (WALD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.